Biggest News Aggregation in the World
📰 Phase News

Page 1476 - Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Phase. Real-time updates on events, politics, business and more.

OSE Immunotherapeutics Receives Authorization for Phase 1 Clinical Trial of its Multi-Target Multi-Variant COVID-19 Vaccine

OSE Immunotherapeutics Receives Authorization for Phase 1 Clinical Trial of its Multi-Target Multi-Variant COVID-19 Vaccine CoVepiT is a SARS-COV-2 vaccine activating T cell defenses through CD8 T-cell multi-epitope* responses. CoVepiT epitopes are selected from 11 viral protein targets and designed to cover all initial and new emerging SARS-CoV-2 variants. CoVepiT, as second-generation vaccine, potentially provides long-term cellular immunity with memory T cells. Regulatory News: OSE Immunoth...
Alexis Peyroles Chris Maggos Isabel Leroux Roels Florence Portejoie Darren Opland Belgian Federal Agency For Medicines

South Carolinians 16 and older now eligible for COVID-19 vaccine; only Pfizer available for youngest

South Carolinians 16 and older now eligible for COVID-19 vaccine; only Pfizer available for youngest South Carolinians 16 and older now eligible for COVID-19 vaccine; only Pfizer available for youngest By Kaitlin Stansell | March 31, 2021 at 7:07 PM EDT - Updated March 31 at 8:19 PM CHARLESTON, S.C. (WCSC) - As of Wednesday, Mar. 31, the COVID-19 vaccines are available to anyone 16 and older in South Carolina. However, while state health officials are urging people to make their appointmen...
South Carolina United States Jaiden Callahan Nick Davidson Sarah Coker Drug Administration

Kadmon Holdings, Inc.: Kadmon Doses First Patient in Open-Label Phase 2 Clinical Trial of Belumosudil in Systemic Sclerosis

(0) NEW YORK, NY / ACCESSWIRE / April 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced that the first patient has been dosed in an open-label Phase 2 clinical trial of belumosudil, the Companys ROCK2 inhibitor, in patients with diffuse cutaneous systemic sclerosis (dcSSc), a chronic immune disorder characterized by fibrosis of the skin and internal organs. The Phase 2 study (KD025-215) will enroll up to 15 adults with dcSSc who will receive orally administered belumosudil 200 mg tw...
United States Harlanw Waksal Ellen Cavaleri Exchange Commission Kadmon Holdings Inc Drug Administration

Gov. Parson to hold COVID-19 briefing Thursday afternoon

JEFFERSON CITY- Governor Mike Parson held his weekly COVID-19 briefing Thursday afternoon at the state Capitol. State health director Dr. Randall Williams was also present at the briefing.  It was the first briefing since he announced the activation dates of Phase 2 and Phase 3 of Missouris vaccination plan, two weeks ago. Dr. Williams touched on the recent Pfizer/BioNTech study that said the vaccine was well tolerated in youths ages 12 to 15. He said he has talked with pediatricians and ...
United States Mike Parson Jefferson City Randall Williams மிச Ou ரி ஒன்றுபட்டது மாநிலங்களில்
Source: komu.com

SC officials expect surge in vaccine supply as millions more get in line

SC officials expect surge in vaccine supply as millions more get in line SC officials expect surge in vaccine supply as millions more get in line By Emily Wakeman | April 1, 2021 at 12:28 PM EDT - Updated April 1 at 12:28 PM COLUMBIA, S.C. (WIS) - Everyone who is 16 and older may now get a COVID-19 vaccine in South Carolina. It’s a milestone Nick Davidson, DHEC’s Senior deputy for public health, said South Carolina reached sooner than expected. “This truly is a monumental feat,” Da...
South Carolina United States Nick Davidson South Carolinians Covid 19 How To
Source: wistv.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

MaaT Pharma Announces Positive Topline Results from Phase 2 HERACLES Clinical Trial with Lead Microbiome Ecosystem Therapy MaaT013 in Patients with Acute Graft-versus-Host Disease

(0) Study meets primary and key secondary objectives with positive impact and favorable overall safety profile in 21 heavily pre-treated and immunocompromised patients with steroid-resistant, gastrointestinal-predominant aGvHD following stem cell transplantation Results in line with previously observed data from a larger patient population treated with MaaT013 as part of an early access program MaaT013 expected to advance into pivotal Phase 3 program MaaT Pharma announced today positive top...
Saint Antoine France General Kostenloser Wertpapierhandel John Weinberg Mohamad Mohty Cellular Therapy Department

Kellogg to invest in Pringles plant in Belgium

Kellogg also looking to invest in energy consumption at the plant US cereal and snacks giant Kellogg is investing at one of the two factories the company has in Europe producing Pringles. Kellogg is spending EUR30m (US$32.7m) on work at its plant in the Belgian city of Mechelen, which manufactures Pringles that go on sale in Europe, north Africa and the Middle East. Part of the work will see a new fryer installed at the facility, which Peter Vanpuyvelde, the plants operation manager, said woul...
Region Flamande United Kingdom Peter Vanpuyvelde Steve Cahillane Kellogg Pringles European Championships

Versantis Announces Positive Phase 1b Results for VS-01 in Patients with Decompensated Cirrhosis

Versantis Announces Positive Phase 1b Results for VS-01 in Patients with Decompensated Cirrhosis Promising data supports advancing VS-01 into Phase 2a POC study in Acute on Chronic Liver Failure Versantis, a clinical-stage company developing novel therapies for orphan liver and pediatric diseases, today announced positive results from a Phase 1b clinical trial of VS-01 in decompensated liver cirrhosis. VS-01 was found to be safe and well tolerated in this first-in-human, single ascending and mu...
Kostenloser Wertpapierhandel Meriam Kabbaj Vincent Foster Jonel Trebicka Vincent Forster Lorenz Pabijan

Updated Vaccination Timeline Announced

Updated Vaccination Timeline Announced Massachusetts Governor Charlie Baker’s administration today announce that all residents and certain worker groups will be eligible for a vaccine. The State’s detailed timeline parallels the original timeline for the three phases announced in December.   According to the administration they have received assurances from the federal government that increased vaccine supply will be available to states soon.  Depending on supply, it could take weeks for...
United States Hynes Convention Center Eastfield Mall Gillette Stadium Charlie Baker Doubletree Hotel In Danvers
Source: wnaw.com

Cole County vaccination appointments open for Friday clinic

The event is for eligible Missouri residents; those in Phase 1A or Phase 1B.  Register and schedule through states vaccine navigator. During the registration process, provide the event code 65991. If you need additional assistance with the registration process, call 877-435-8411. If you do not use the event code provided, the event will not show up in navigator for you to schedule an appointment time. The vaccination event will take place at The Linc in Cole County on Friday, March 19. Th...
Cole County United States The Linc Sign Up Mass Vaccination Covid 19
Source: komu.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science